PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) Operating income 2016–2025
PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) annual operating income history from SEC filings — each fiscal year as reported.
-$5.3MFY2025 · since FY2016: -$24.5M → -$5.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$5.3M | -16.8% |
| FY2024 | -$4.5M | -56.2% |
| FY2023 | -$2.9M | +15.4% |
| FY2022 | -$3.4M | +26.6% |
| FY2021 | -$4.7M | +5.9% |
| FY2020 | -$5.0M | +21.2% |
| FY2019 | -$6.3M | +21.8% |
| FY2018 | -$8.1M | +39.5% |
| FY2017 | -$13.3M | +45.7% |
| FY2016 | -$24.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice